HT29 In Vivo Tumorigenesis Assay

This assay is to provide HT29-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

HT29

Human

HT-29 is a cell line from a White, female colorectal adenocarcinoma patient that can be used in cancer and toxicology research.

HT-29

Colorectal Adenocarcinoma

Oncology

In Vivo Tumorigenesis Assay

HT29-cell based In Vivo Tumorigenesis Assay

Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.

Oncology In Vivo Assays